Identification of a potent and selective 5-HT6 antagonist:: One-step synthesis of (E)-3-(benzenesulfonyl)-2-(methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrile

被引:26
作者
Wu, YJ
He, H
Hu, SH
Huang, YZ
Scola, PM
Grant-Young, K
Bertekap, RL
Wu, DD
Gao, Q
Li, Y
Klakouski, C
Westphal, RS
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Neurosci Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Early Discovery Chem, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Neurosci Biol, Wallingford, CT 06492 USA
[4] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Analyt Sci, Wallingford, CT 06492 USA
[5] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Comp Aided Drug Design, Wallingford, CT 06492 USA
[6] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Lead Profiling, Wallingford, CT 06492 USA
关键词
D O I
10.1021/jm034142q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
(E)-3-(Benzenesulfonyl)-2-(methylsulfanyl)pyrido[1,2-alpha]pyrimidin-4-ylidenamine (7) was found to be a potent and selective 5-HT6 antagonist. A one-step synthesis of this compound is described.
引用
收藏
页码:4834 / 4837
页数:4
相关论文
共 27 条
[1]   Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats [J].
Bentley, JC ;
Bourson, A ;
Boess, FG ;
Fone, KCF ;
Marsden, CA ;
Petit, N ;
Sleight, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1537-1542
[2]  
BOURSON A, 1995, J PHARMACOL EXP THER, V274, P173
[3]   5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046):: A potent, selective, and orally bioavailable 5-HT6 receptor antagonist [J].
Bromidge, SM ;
Brown, AM ;
Clarke, SE ;
Dodgson, K ;
Gager, T ;
Grassam, HL ;
Jeffrey, PM ;
Joiner, GF ;
King, FD ;
Middlemiss, DN ;
Moss, SF ;
Newman, H ;
Riley, G ;
Routledge, C ;
Wyman, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :202-205
[4]   Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists:: Identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134) [J].
Bromidge, SM ;
Clarke, SE ;
Gager, T ;
Griffith, K ;
Jeffrey, P ;
Jennings, AJ ;
Joiner, GF ;
King, FD ;
Lovell, PJ ;
Moss, SF ;
Newman, H ;
Riley, G ;
Rogers, D ;
Routledge, C ;
Serafinowska, H ;
Smith, DR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (01) :55-58
[5]   In vivo effects of the 5-HT6 antagonist SE-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate [J].
Dawson, LA ;
Nguyen, HQ ;
Li, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :23-26
[6]   The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus [J].
Dawson, LA ;
Nguyen, HQ ;
Li, P .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (05) :662-668
[7]   Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system [J].
Gerard, C ;
Martres, MP ;
Lefevre, K ;
Miquel, MC ;
Verge, D ;
Lanfumey, L ;
Doucet, E ;
Hamon, M ;
ElMestikawy, S .
BRAIN RESEARCH, 1997, 746 (1-2) :207-219
[8]   KETENDERIVATE .2. REAKTIONEN SUBSTITUIERTER KETENMERCAPTALE [J].
GOMPPER, R ;
TOPFL, W .
CHEMISCHE BERICHTE-RECUEIL, 1962, 95 (12) :2871-&
[9]   Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors [J].
Hamon, M ;
Doucet, E ;
Lefevre, K ;
Miquel, MC ;
Lanfumey, L ;
Insausti, R ;
Frechilla, D ;
Del Rio, J ;
Vergé, D .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (02) :S68-S76
[10]  
Kohen R, 1996, J NEUROCHEM, V66, P47